Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471623 · ClinicalTrials.gov registry record · NA
Decentralized Trial in Atrial Fibrillation Patients
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT04471623: Completed NA study, sponsored by Stanford University.
NCT04471623 is a NA study that has completed, run by Stanford University. The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04471623, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
The purpose of this study is to validate an approach to decentralize, or virtualize, the clinical trial experience for enrolled subjects, through the coordinated use of multiple digital health and telehealth technologies. The study aims to validate the feasibility, acceptability and best practices of coordinating/integrating several individual digital health technologies to achieve execution of high compliance, cost-efficient, and scientifically sound clinical trials.
Interventions
- BEHAVIORAL Use of DeTAP App and Home Devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2020-08-10 |
| Est. Completion | 2021-03-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04471623
The ClinicalTrials.gov registry entry for NCT04471623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Use of DeTAP App and Home Devices is the first listed.
NCT04471623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04471623 about?
NCT04471623 is a clinical study titled "Decentralized Trial in Atrial Fibrillation Patients". The purpose of this study is to validate an approach to decentralize, or virtualize, the clinical trial experience for enrolled subjects, through the coordinated use of multiple digital health and telehealth technologies. The study aims to validate the feasibility, acceptability and best practices o...
What is the current status of trial NCT04471623?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2020-08-10. Estimated completion is 2021-03-12.
What interventions are being tested in trial NCT04471623?
The interventions under investigation include: Use of DeTAP App and Home Devices (BEHAVIORAL).
Who is sponsoring clinical trial NCT04471623?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.